Physician profile
Ajaz Umerani
NPI 1104927797
$1,812.22
in general payments reported to CMS, 2019-2025
27 companies · $689 in 2025
The $689 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $128 · 2021: $287 · 2022: $75.85 · 2023: $239 · 2024: $221 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $471.47 | 2021-2025 | Venaseal, Closurefast, Closurerfs |
| Boston Scientific Corporation | $229.29 | 2021-2025 | Varithena Administration Pack |
| Astrazeneca Pharmaceuticals Lp | $159.25 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Organogenesis INC. | $158.79 | 2025 | Puraply Wound Matrix, Affinity |
| Novo Nordisk INC | $110.80 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.39 | 2022-2025 | Eliquis, Camzyos |
| Exact Sciences Corporation | $75.48 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $58.48 | 2021-2025 | Vraylar |
| Pfizer INC. | $50.76 | 2020-2025 | |
| Amarin Pharma, INC. | $47.69 | 2019-2021 | |
| Lilly USA, LLC | $42.85 | 2020-2025 | Mounjaro, Zepbound |
| Biocompatibles, INC. | $35.37 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.41 | 2019-2020 | |
| Medtronic Vascular, INC. | $29.30 | 2020 | |
| Tactile Systems Technology INC | $29.02 | 2025 | Flexitouch Plus, Nimbl |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.52 | 2021 | |
| Irhythm Technologies, INC. | $19.37 | 2023 | Zio Xt Patch |
| Si-Bone, INC. | $19.04 | 2021 | |
| Astellas Pharma US INC | $19.02 | 2021 | |
| Amgen INC. | $16.65 | 2025 | Evenity, Prolia |
| Bluewind Medical | $16.10 | 2025 | Revi |
| Radius Health, INC. | $15.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2019 | |
| Merck Sharp & Dohme LLC | $12.48 | 2019 | |
| Glaxosmithkline, LLC. | $12.15 | 2020 | |
| Xeris Pharmaceuticals, INC. | $11.88 | 2021 | |
| Venclose INC. | $7.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajaz Umerani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.